Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Role of orexin-A in experimental autoimmune encephalomyelitis.
Visual field impairment captures disease burden in multiple sclerosis.
Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Vision and vision-related outcome measures in multiple sclerosis.
What is Susac syndrome? - A brief review of articles.
Correlates of participation in meaningful activities among people with multiple sclerosis.
Electropysiologic evaluation of the visual pathway in patients with multiple sclerosis.
Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide.
Optic Neuritis as Isolated Manifestation of Leptomeningeal Carcinomatosis: A Case Report and Systematic Review of Ocular Manifestations of Neoplastic Meningitis.
The new era of multiple sclerosis therapy.
Complement in neurobiology.
Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
Microglia and neuroprotection.
Sex-Based Differences in Multiple Sclerosis (Part I): Biology of Disease Incidence.
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerations.
Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence.
Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models.
Time to target brain atrophy and neurodegeneration in multiple sclerosis.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Understanding the pharmacology of stroke and multiple sclerosis through imaging.
Pages
« first
‹ previous
…
630
631
632
633
634
635
636
637
638
…
next ›
last »